EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for DWTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -0.3378
March 31, 2026 -0.1487
December 31, 2025 -0.2603
September 30, 2025 -8.203
June 30, 2025 -1.992
March 31, 2025 -8.450
December 31, 2024 -6.289
September 30, 2024 -2.054
June 30, 2024 -1.146
March 31, 2024 -1.676
December 31, 2023 -1.432
September 30, 2023 -1.617
June 30, 2023 -1.956
March 31, 2023 -2.069
Date Value
December 31, 2022 -2.788
September 30, 2022 -6.999
June 30, 2022 -11.01
March 31, 2022 -11.88
December 31, 2021 -13.54
September 30, 2021 -12.33
June 30, 2021 -12.85
March 31, 2021 -9.176
December 31, 2020 -19.57
September 30, 2020 -8.222
June 30, 2020 -1.976
September 30, 2019 -2.450
June 30, 2019 -1.714

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.1822
Alnylam Pharmaceuticals, Inc. 1.207
Anika Therapeutics, Inc. 0.2412
Savara, Inc. -0.1587
Vericel Corp. 0.0422

EPS Diluted (Quarterly) Related Metrics